Forward Pharmaceuticals
Forward Pharmaceuticals is a China-based biotechnology company running 2 late-stage cancer trials of FWD1802 in HR-positive / HER2-negative breast cancer.
Overview
Forward Pharmaceuticals, based in Shenzhen, China, is a biotechnology company. Forward Pharma is a clinical-stage biotechnology company focused exclusively on oncology drug development, using structural characterisation, biophysical profiling and computational optimisation. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing FWD1802 in HR-positive / HER2-negative breast cancer. The largest, NCT07002177 (A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC), plans to enrol 196 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyOlema Pharmaceuticals
Shares HR-positive / HER2-negative breast cancer and the tag ctgov-sponsor.
- CompanyTreadwell Therapeutics
Shares HR-positive / HER2-negative breast cancer and the tag ctgov-sponsor.
- CompanyOncolytics Biotech
Shares HR-positive / HER2-negative breast cancer and the tag ctgov-sponsor.
- CompanyMBrace Therapeutics
Shares HR-positive / HER2-negative breast cancer and the tag ctgov-sponsor.
- CompanyShenzhen Ionova Life Sciences
Shares HR-positive / HER2-negative breast cancer and the tag ctgov-sponsor.
- CompanyXuanzhu Biopharmaceutical
Shares HR-positive / HER2-negative breast cancer and the tag ctgov-sponsor.
- CompanyEllipses Pharma
Shares HR-positive / HER2-negative breast cancer and the tag ctgov-sponsor.
- CompanyNuvation Bio
Shares HR-positive / HER2-negative breast cancer and the tag ctgov-sponsor.